Cargando…
Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630262/ https://www.ncbi.nlm.nih.gov/pubmed/37707704 http://dx.doi.org/10.1007/s40120-023-00536-y |
| _version_ | 1785146012543746048 |
|---|---|
| author | Lager, Brittney Liseno, Jacob Božin, Ivan England, Sarah M. Shankar, Sai L. Mendoza, Jason P. Lewin, James B. |
| author_facet | Lager, Brittney Liseno, Jacob Božin, Ivan England, Sarah M. Shankar, Sai L. Mendoza, Jason P. Lewin, James B. |
| author_sort | Lager, Brittney |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10630262 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106302622023-11-14 Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” Lager, Brittney Liseno, Jacob Božin, Ivan England, Sarah M. Shankar, Sai L. Mendoza, Jason P. Lewin, James B. Neurol Ther Letter Springer Healthcare 2023-09-14 /pmc/articles/PMC10630262/ /pubmed/37707704 http://dx.doi.org/10.1007/s40120-023-00536-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Lager, Brittney Liseno, Jacob Božin, Ivan England, Sarah M. Shankar, Sai L. Mendoza, Jason P. Lewin, James B. Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title | Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title_full | Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title_fullStr | Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title_full_unstemmed | Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title_short | Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis” |
| title_sort | response to letter to the editor regarding “real-world analysis affirms the high persistence and adherence observed with diroximel fumarate in patients with multiple sclerosis” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630262/ https://www.ncbi.nlm.nih.gov/pubmed/37707704 http://dx.doi.org/10.1007/s40120-023-00536-y |
| work_keys_str_mv | AT lagerbrittney responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT lisenojacob responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT bozinivan responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT englandsarahm responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT shankarsail responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT mendozajasonp responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis AT lewinjamesb responsetolettertotheeditorregardingrealworldanalysisaffirmsthehighpersistenceandadherenceobservedwithdiroximelfumarateinpatientswithmultiplesclerosis |